Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma.
about
Analysis of tissue specimens by matrix-assisted laser desorption/ionization imaging mass spectrometry in biological and clinical research.Multiple statistical analysis techniques corroborate intratumor heterogeneity in imaging mass spectrometry datasets of myxofibrosarcomaPerspectives in imaging using mass spectrometryDiabetic nephropathy induces alterations in the glomerular and tubule lipid profiles.Quality measures of imaging mass spectrometry aids in revealing long-term striatal protein changes induced by neonatal exposure to the cyanobacterial toxin β-N-methylamino-L-alanine (BMAA)Imaging the clear cell renal cell carcinoma proteome.Imaging mass spectrometry--a new and promising method to differentiate Spitz nevi from Spitzoid malignant melanomas.Spatial mapping by imaging mass spectrometry offers advancements for rapid definition of human skin proteomic signatures.Recent advances in single-cell MALDI mass spectrometry imaging and potential clinical impactMALDI imaging mass spectrometry of human tissue: method challenges and clinical perspectives.MALDI imaging mass spectrometry--painting molecular picturesMatrix-assisted laser desorption/ionisation mass spectrometry imaging and its development for plant protein imaging.MALDI Imaging Mass Spectrometry (MALDI-IMS)-application of spatial proteomics for ovarian cancer classification and diagnosis.In situ molecular imaging of proteins in tissues using mass spectrometry.Detection of molecular signatures of oral squamous cell carcinoma and normal epithelium - application of a novel methodology for unsupervised segmentation of imaging mass spectrometry data.MALDI imaging of post-mortem human spinal cord in amyotrophic lateral sclerosis.Differentiating tumor heterogeneity in formalin-fixed paraffin-embedded (FFPE) prostate adenocarcinoma tissues using principal component analysis of matrix-assisted laser desorption/ionization imaging mass spectral data.Low C24-OH and C22-OH sulfatides in human renal cell carcinoma.The use of biophysical proteomic techniques in advancing our understanding of diseases.Deep learning and 3D-DESI imaging reveal the hidden metabolic heterogeneity of cancerIn situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontologyApproaching MALDI molecular imaging for clinical proteomic research: current state and fields of application.MALDI tissue imaging: from biomarker discovery to clinical applications.Protein signatures for survival and recurrence in metastatic melanoma.Imaging of intact tissue sections: moving beyond the microscopeL-DOPA-induced dyskinesia is associated with regional increase of striatal dynorphin peptides as elucidated by imaging mass spectrometry.MALDI imaging mass spectrometry for direct tissue analysis: technological advancements and recent applications.MALDI imaging of lipid biochemistry in tissues by mass spectrometry.High speed data processing for imaging MS-based molecular histology using graphical processing units.Challenges and recent advances in mass spectrometric imaging of neurotransmitters.Tissue-based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer.MALDI MS imaging as a tool for biomarker discovery: methodological challenges in a clinical setting.Lipid imaging by mass spectrometry - a review.Comprehensive identification of proteins from MALDI imaging.MALDI imaging mass spectrometry in glomerulonephritis: feasibility study.Dithranol as a matrix for matrix assisted laser desorption/ionization imaging on a fourier transform ion cyclotron resonance mass spectrometerMALDI imaging mass spectrometry profiling of proteins and lipids in clear cell renal cell carcinomaThe Role of Proteomics in the Diagnosis and Treatment of Women's Cancers: Current Trends in Technology and Future OpportunitiesDe novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry.The use of matrix coating assisted by an electric field (MCAEF) to enhance mass spectrometric imaging of human prostate cancer biomarkers.
P2860
Q28396816-7FAE746F-A0BC-41FC-902B-4015BD534B0AQ28477284-C0C50209-F8EE-4946-ABAD-A73362DD20DFQ30048062-A28F58C2-EFC0-48C4-8F3C-B34C68255CF1Q30407920-79F70499-DEA1-4294-8681-A476911DD0EEQ30444494-F812CA9F-3CDC-47CA-8E07-05F578D50195Q30457782-FF817539-AEF0-432A-96E1-A06B998474EAQ30458512-1743E538-1797-4605-A4D8-2E1A5A9FB53CQ30465135-0FFE7682-9AE6-4D7B-9D54-AF79585D01F4Q30465139-A349FC71-B63A-4343-896E-580C6E9A157AQ30470146-E1525B4F-BF55-43E0-BB4A-F9EBE8E80635Q30472639-22816D91-2EB8-4037-BC87-A0AE988205D3Q30474754-7140F0AC-A78E-47F5-A300-EA944D19C22CQ30476935-EB294DE4-E1BB-4EA5-BE8F-C49A57008CD5Q30479962-B3D2EFC7-0F53-4879-A275-AF89CA4F4F76Q31095350-20924042-EB4B-4024-A308-53C4F261F4A9Q31096152-31225E0A-23BC-469B-A680-F6AC613EF91DQ31139690-D6E402E6-A53E-43A6-8A49-D206E38D5B64Q31160691-27CFDDA3-77D3-43F3-A0D0-26C762C828BEQ33639590-22F1084F-01D5-4748-B650-D16953DE4FD3Q33640189-70AF86A8-C4CF-4887-BAFF-6B4CEF4755A2Q33672680-369E6308-D8EA-4CB0-8E1F-5164951FB6BCQ33766329-8F97B39A-12FB-49AE-85AE-781C6476887CQ33889595-01541CA4-E5FD-4FCC-96FC-79358AF57A80Q33891766-1788D9C8-9DE9-410B-90AE-E8790AA80ECBQ33919463-44B27C75-D607-43C7-B272-37E32F469B02Q33954124-F28EB1F4-6A47-4BF9-A49E-EDA5761E582BQ33976656-4652B9EA-3F45-4065-85AD-4162C5B531F3Q34028743-B0D13C93-26ED-41B5-B562-95FCAC899B68Q34152425-C7D504CB-49E8-4A3C-99AE-0533C8A4DF44Q34157765-C4995841-A5AF-47C5-AEA8-9277B5F27EE0Q34202435-A518E15C-7C06-4537-A41F-51BD9FBED2D2Q34454885-D4E5CEF9-C400-4C10-BC44-827B5829E8C7Q34546576-8861F7D9-0BC8-4F7B-BD89-FD36D4A964F9Q34778073-92095D05-6A4E-4E53-8755-5E7964F3A17DQ35054439-0F548A9E-AC08-4FEC-AF80-887FA6713CCDQ35058139-A10AC367-6B68-49C7-9D06-00644954C02DQ35090735-DB6589C1-E56A-42B2-9C78-ED89BBFF9A92Q35185640-0F6D2009-50E4-4B64-9DDB-0C1E2C07C82FQ35243470-80954E8C-9B25-4A15-B507-D3BB974E8237Q35891644-C3B9A3CD-7033-4B69-89D5-4ABA9FD04196
P2860
Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma.
@ast
Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma.
@en
type
label
Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma.
@ast
Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma.
@en
prefLabel
Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma.
@ast
Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma.
@en
P2093
P2860
P356
P1476
Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma.
@en
P2093
Melinda E Sanders
Richard M Caprioli
Stacey R Oppenheimer
P2860
P304
P356
10.1021/PR900936Z
P577
2010-05-01T00:00:00Z